Previous studies demonstrated that release of PAMPs and DAMPs upon tissue damage after conditioning treatment triggered synthesis of pro-IL-1β and activation of NLRP3 inflammasome respectively, leading to an promoted inflammatory response which impacts the development and severity of graft versus host disease (GVHD)36, 37. Here, IL1B is linked to graft versus host disease.